IHL 0.00% 4.1¢ incannex healthcare limited

News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol, page-6

  1. 137 Posts.
    lightbulb Created with Sketch. 75
    Good news but IRB approval required for Germany, Spain and Finland sites as well, disappointing price action reminiscent of the ASX days.
    Last edited by danishcookie: 18/01/24
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.